It is recognized that ulcerative colitis (UC) predisposes to the developmen
t of colorectal adenocarcinoma (CRC), and the molecular pathway for this pr
ocess differs from that for sporadic CRCs. However, several important detai
ls regarding the risk factors for and the molecular changes underlying UC-r
elated colorectal carcinogenesis have only come to light lately. First, rec
ent data suggest environmental factors related to long-standing inflammatio
n contribute more to this increased cancer risk than an inherited susceptib
ility. Second, molecular changes that may represent the first steps in the
development of neoplasia are being increasingly identified in non-dysplasti
c, colitic mucosa. Third, there is now good evidence suggesting that UC-rel
ated CRC may develop along more than one molecular pathway. These emerging
data will hopefully contribute to attempts to prevent the development of UC
-related CRC, e.g. through refining surveillance programmes. Details of the
molecular heterogeneity of UC-related dysplasia and CRC may also help deve
lop reliable tools for diagnosing the former and for predicting the behavio
ur of the latter. Finally, there is increasing awareness of non-epithelial
colorectal malignancies which are associated with UC and may potentially in
crease in incidence with changes in the medical management of this inflamma
tory disease.